Volume 4 Issue 21, October 10, 2017
After receiving her MBA from IE business school and a PhD in nanomedicine from Groningen University in Holland, Teresa became the head of the US office for Venture Valuation, where the global team evaluated healthcare companies facing a fundraising event, licensing deals, or an M+A transaction. She was also the CEO and co-founder of Ambiox Biotech (application of dendrimer nanotechnology for antiviral treatment). She regularly speaks at healthcare conferences in the Pharma/Biotech/Medtech/CRO sectors. She has co-authored two patents in nanotechnology and drug delivery and she was awarded the 2011 MIT TR35 Innovator of the Year award by the Massachusetts Institute of Technology. Teresa was honored to be among the top 100 women leaders in Spain in the entrepreneurial and innovative category for two consecutive years in 2012 and 2013. In addition, she was selected as Woman of the Year by the magazine Scientific Entrepreneurial Woman Today.